This 15-minute accredited CME publication reviews the benefits and limitations of antinuclear antibody (ANA) testing and its utility in systemic lupus erythematosus (SLE). Highlights include an examination of ANA expression in SLE, the role of ANA testing in clinical trials, challenges associated with currently available assays, and novel approaches for ANA testing. In addition, this activity features a short video with expert commentary on ANA testing in SLE.
Continuing Medical Education
David Stephen Pisetsky, MD, PhD
Professor of Medicine
Professor of Immunology
This brief accredited CME publication highlights a new categorization system for common symptoms experienced by patients with systemic lupus erythematosus (SLE), as well as for the patients themselves. It also discusses the utility of this categorization system in improving the quality and effectiveness of SLE care and its impact on the evaluation of new agents under clinical investigation for the treatment of SLE.
Jennifer Lee Rogers, MD
Assistant Professor of Medicine
Division of Rheumatology and Immunology